MedPath

Periodontal Therapy in a Primary Prevention of Cardiovascular Disease

Phase 2
Completed
Conditions
Periodontitis
Coronary Disease
Interventions
Behavioral: Integrated Care Group
Other: Standard Care Group
Registration Number
NCT02081976
Lead Sponsor
Macmillan Research Group UK
Brief Summary

Cardiovascular diseases (CVD) are still considered the main cause of mortality and morbidity all over the world. In the last years, efforts have been made to define more effective therapeutic and preventive strategies.Periodontal diseases have been considered a probable risk factor for CVD with a great amount of evidence from observational studies. Although there are some interventional studies evaluating the systemic effects of periodontal therapy, there is little information regarding the impact of periodontal treatment on the prevention of cardiovascular events. To the best of our knowledge, there are no randomized controlled trials published to date assessing the effect of periodontal therapy in primary prevention of CVD.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
57
Inclusion Criteria
  • Individuals having at least 50% of their dentition with periodontal probing pocket depths N4 mm and
  • With documented radiographic alveolar bone loss were included
Exclusion Criteria
  • Known systemic diseases
  • History and/or presence of other infections
  • Systemic antibiotic treatment in the preceding 3 months
  • Treatment with any medication known to affect the serum level of inflammatory markers, lipids, or BP
  • Pregnant or lactating females
  • Allergy to tetracyclines

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Integrated Care GroupIntegrated Care Groupa combined treatment approach of Dental Therapist, Dental Hygienist, Cardiologist along with counselor
Standard Care GroupStandard Care GroupDental therapist providing standard periodontal treatment
Primary Outcome Measures
NameTimeMethod
Traditional cardiovascular risk markers (total cholesterol, LDL-C, HDL-C and triglycerides)Change from baseline to six month
Secondary Outcome Measures
NameTimeMethod
High- and low-density lipoprotein cholesterolChange from baseline to six month
cardiovascular risk scores (Framingham)Change from baseline to six months

Trial Locations

Locations (1)

GyanSanjeevani

🇮🇳

Jaipur, Rajasthan, India

© Copyright 2025. All Rights Reserved by MedPath